280 assets in Pancreatic Ductal Adenocarcinoma

Therapeutic assets addressing Pancreatic Ductal Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Zentalis Pancreatic Ductal Adenocarcinoma	Brandon Huffman, MD	P2	CCC (48)
CD318-CAR-T cells Pancreatic Ductal Adenocarcinoma	University Hospital Tuebingen	P1/2	CC (47)
Perflubutane Pancreatic Ductal Adenocarcinoma	Flemming Forsberg	P1/2	CC (47)
Xer-001 Pancreatic Ductal Adenocarcinoma	Xerient Pharma	P1/2	CC (47)
Elironrasib Pancreatic Ductal Adenocarcinoma	Revolution Medicines, Inc.	P1/2	CC (46)
Edv-Gc Pancreatic Ductal Adenocarcinoma	Engeneic Pty Limited	P1/2	CC (45)
E-Edv-D682 Pancreatic Ductal Adenocarcinoma	Engeneic Pty Limited	P1/2	CC (45)
gfh276 Pancreatic Ductal Adenocarcinoma	Genfleet Therapeutics (Shanghai) Inc.	P1/2	CC (45)
gfh375 Pancreatic Ductal Adenocarcinoma	Genfleet Therapeutics (Shanghai) Inc.	P1/2	CC (45)
Ifebemtinib Pancreatic Ductal Adenocarcinoma	InxMed (Shanghai) Co., Ltd.	P1/2	CC (45)
Jab-21822 Pancreatic Ductal Adenocarcinoma	Allist Pharmaceuticals, Inc.	P1/2	CC (45)
Jab-23E73 Pancreatic Ductal Adenocarcinoma	Jacobio Pharmaceuticals Co., Ltd.	P1/2	CC (45)
Narmafotinib Pancreatic Ductal Adenocarcinoma	Amplia Therapeutics Limited	P1/2	CC (45)
ont01 Pancreatic Ductal Adenocarcinoma	Washington University School of Medicine	P1/2	CC (45)
Pegcetacoplan Pancreatic Ductal Adenocarcinoma	Roswell Park Cancer Institute	P1/2	CC (45)
Pertzye Pancreatic Ductal Adenocarcinoma	Memorial Sloan Kettering Cancer Center	P1/2	CC (45)
Pyruvate Pancreatic Ductal Adenocarcinoma	University of California, San Francisco	P2	CC (45)
RNK08954 Pancreatic Ductal Adenocarcinoma	InxMed (Shanghai) Co., Ltd.	P1/2	CC (45)
tng462 Pancreatic Ductal Adenocarcinoma	Tango Therapeutics, Inc.	P1/2	CC (45)
Trastuzumab Deruxtecan Pancreatic Ductal Adenocarcinoma	National Cancer Institute (NCI)	P1/2	CC (45)
Fluoromisonidazole Pancreatic Ductal Adenocarcinoma	National Cancer Institute (NCI)	P2	CC (44)
Lorigerlimab Pancreatic Ductal Adenocarcinoma	MacroGenics	P1	CC (44)
Retifanlimab Pancreatic Ductal Adenocarcinoma	Peter Hosein, MD	P1	CC (44)
[177lu]lu-dpi-4452 Pancreatic Ductal Adenocarcinoma	ITM Oncologics GmbH	P1/2	CC (43)
68ga-dfc413 Pancreatic Ductal Adenocarcinoma	Novartis Pharmaceuticals	P1	CC (43)
[68ga]ga-dpi-4452 Pancreatic Ductal Adenocarcinoma	ITM Oncologics GmbH	P1/2	CC (43)
68Ga-NNS309 Pancreatic Ductal Adenocarcinoma	Novartis Pharmaceuticals	P1	CC (43)
Adebrelimab Pancreatic Ductal Adenocarcinoma	West China Hospital	P1/2	CC (43)
ak112 Pancreatic Ductal Adenocarcinoma	Akeso	P1	CC (43)
ak154 Pancreatic Ductal Adenocarcinoma	Akeso	P1	CC (43)
Arry-558 Pancreatic Ductal Adenocarcinoma	Pfizer	P1	CC (43)
Biological Ni-1801 Pancreatic Ductal Adenocarcinoma	Light Chain Bioscience - Novimmune SA	P1	CC (43)
Bms-986523 Pancreatic Ductal Adenocarcinoma	Bristol-Myers Squibb	P1/2	CC (43)
Bpi-572270 Pancreatic Ductal Adenocarcinoma	Betta Pharmaceuticals Co., Ltd.	P1/2	CC (43)
Cholestyramine Pancreatic Ductal Adenocarcinoma	City of Hope Medical Center	P1	CC (43)
Cobicistat Pancreatic Ductal Adenocarcinoma	German Cancer Research Center	P1	CC (43)
da-3501 Pancreatic Ductal Adenocarcinoma	Dong-A ST Co., Ltd.	P1	CC (43)
Dual-Target Antigen-Selected Car-Nk Pancreatic Ductal Adenocarcinoma	Essen Biotech	P1/2	CC (43)
Eb-Dnk101 Dual-Targeting Car-Nk Cells Pancreatic Ductal Adenocarcinoma	Beijing Biotech	P1/2	CC (43)
Eb-Dnk102 Dual-Targeting Car-Nk Cells Pancreatic Ductal Adenocarcinoma	Beijing Biotech	P1/2	CC (43)
Eb-Select Single-Target Car-Nk Cells Pancreatic Ductal Adenocarcinoma	Essen Biotech	P1/2	CC (43)
gen1042 Pancreatic Ductal Adenocarcinoma	Genmab	P1/2	CC (43)
Hafnium Oxide Pancreatic Ductal Adenocarcinoma	M.D. Anderson Cancer Center	P1	CC (43)
Ivonescimab Pancreatic Ductal Adenocarcinoma	Akeso	P1	CC (43)
Leflunomide Pancreatic Ductal Adenocarcinoma	City of Hope Medical Center	P1	CC (43)
Ligritinib Pancreatic Ductal Adenocarcinoma	Jonsson Comprehensive Cancer Center	P1	CC (43)
mt-4561 Pancreatic Ductal Adenocarcinoma	Tanabe Pharma America, Inc.	P1/2	CC (43)
pf-07934040 Pancreatic Ductal Adenocarcinoma	Pfizer	P1	CC (43)
pf-07985045 Pancreatic Ductal Adenocarcinoma	Pfizer	P1	CC (43)
pf-08046037 Pancreatic Ductal Adenocarcinoma	Pfizer	P1	CC (43)

Showing 101 to 150 of 280 assets

PreviousPage 3 of 6Next